What’s unique about the company is its patented drug delivery technology. DehydraTECH technology is a method by which we can combine bioactive molecules like THC or CBD or other molecules like non-steroidal anti-inflammatories with certain types of fatty acids such as oleic acid found in sunflower oil and by doing that it allows the molecules to elude flavor receptors in the mouth, it allows those molecules to be faster acting and better absorbed by the human gastrointestinal tract.
Lexaria Bioscience Corp. has developed and out-licenses its disruptive and cost-effective DehydraTECH™ technology that promotes healthier administration methods, lower overall dosing and higher effectiveness of ingestible drugs and other beneficial molecules.
Many vitamins, drugs, supplements and other beneficial molecules are lipophilic (i.e. fat soluble) and difficult for the human gastrointestinal system to efficiently and effectively absorb. DehydraTECH™ greatly improves the body’s ability to absorb these substances so their benefits can be received more quickly and pleasantly.
Lexaria has multiple patents issued or pending in over 40 countries around the world.
For more information on Lexaria Bioscience Corp. (LXRP:OTCQX) please fill out the form below.